1Mier W, Haberkom U, Eisenhut M. ^18F-FLT;portrait of a proliferation marker. Eur J Nucl Med, 2002, 29: 165-169.
2Shields AF, Dohmen BM, Mangner TJ, et al.Metabolism of ^18F-FLT in patients. J Nucl Med,2000, 41 Suppl: 36.
3Sherley JL, Kelly TJ. Regulation of human thymidine kinase during the cell cycle. J Biol Chem, 1988, 263: 8350-8358.
4Coppock DL, Pardee AB. Control of thymidine kinase mRNA during the cell cycle. Mol Cell Biol, 1987, 7: 2925-2932.
5Ito M, Conrad SE. Independent regulation of thymidine kinase mRNA and enzyme levels in serum-stimulated cells. J Biol Chem, 1990,265: 6954-6960.
6Gross MK, Merrill GF. Regulation of thymidine kinase protein levels during myogenic withdrawal from the cell cycle is independent of mRNA regulation. Nucleic Acids Res, 1988, 16: 11625-11643.
7Rasey JS, Grierson JR. 3'-deoxy-3-18F-fluorothymidine (FLT) predicts changes in cell proliferation. J Nucl Med, 1999, 40 Suppl: 25.
8Ellims PH, Van der Weyden MB, Medley G, et al.Thymidine kinase isoenzymes in human malignant lymphoma. Cancer Res, 1981, 41: 691-695.
9Sakamoto S, Iwama T, Tsukada K, et al. Increased activity of thymidine kinase isozyme in human colon tumor. Carcinogenesis, 1984, 5:183-185.
10Nawata H, Kamiya T. Two molecular forms of thymidine kinase in the cytosol of regenerating rat liver. J Biochem, 1975, 78: 1215-1224.
